A randomized-controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia
Objective: Medication adherence is extremely important in preventing relapse and lowering symptoms in schizophrenic patients. However, estimates show that nearly half of these patients have poor adherence. The Brief Adherence Rating Scale (BARS) seems to be the most reliable tool assessing adherence...
Saved in:
Main Authors: | Emmanuel eStip (Author), Philippe D. Vincent (Author), Catherine eGuevremont (Author), Simon eZhornitsky (Author), Constantin eTranulis (Author), Juliette eSablier (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endocannabinoids and Schizophrenia
by: Stéphane Potvin, et al.
Published: (2010) -
Use of long acting antipsychotics and relationship to newly diagnosed bipolar disorder: a pragmatic longitudinal study based on a Canadian health registry
by: Emmanuel Stip, et al.
Published: (2020) -
The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19
by: Emmanuel Stip, et al.
Published: (2020) -
The bold sedentary behavior recommendations in the new Canadian guidelines: are they evidence-based? Response to "Sedentary Behavior Research Network members support new Canadian 24-Hour Movement Guideline recommendations"
by: Emmanuel Stamatakis, et al.
Published: (2020) -
Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen
by: Philippe Hermand, et al.
Published: (2017)